Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Effect of Prostate Magnetic Resonance Imaging/Ultrasound Fusion-guided Biopsy on Radiation Treatment Recommendations.

Reed A, Valle LF, Shankavaram U, Krauze A, Kaushal A, Schott E, Cooley-Zgela T, Wood B, Pinto P, Choyke P, Turkbey B, Citrin DE.

Int J Radiat Oncol Biol Phys. 2017 Apr 1;97(5):947-951. doi: 10.1016/j.ijrobp.2016.12.016. Epub 2016 Dec 18.

PMID:
28333017
2.

Does Leaving the Biopsy Needle in Povidone-Iodine Solution Reduce Infective Complications after Biopsy?

Benli E, Cirakoglu A, Ogreden E, Cetinkol Y, Calgin MK, Ayyildiz A, Yüce A.

Adv Urol. 2016;2016:6841837. doi: 10.1155/2016/6841837. Epub 2016 Dec 20.

3.

Risk of hospitalization and death following prostate biopsy in Scotland.

Brewster DH, Fischbacher CM, Nolan J, Nowell S, Redpath D, Nabi G.

Public Health. 2017 Jan;142:102-110. doi: 10.1016/j.puhe.2016.10.006. Epub 2016 Oct 31.

4.

Release of Cell-free MicroRNA Tumor Biomarkers into the Blood Circulation with Pulsed Focused Ultrasound: A Noninvasive, Anatomically Localized, Molecular Liquid Biopsy.

Chevillet JR, Khokhlova TD, Giraldez MD, Schade GR, Starr F, Wang YN, Gallichotte EN, Wang K, Hwang JH, Tewari M.

Radiology. 2017 Apr;283(1):158-167. doi: 10.1148/radiol.2016160024. Epub 2016 Nov 1.

PMID:
27802108
5.

Efficacy of two-time prophylactic intravenous administration of tazobactam/piperacillin for transrectal ultrasound-guided needle biopsy of the prostate.

Iwamoto H, Shigehara K, Miyagi T, Nakashima T, Shimamura M, Namiki M.

Prostate Int. 2015 Sep;3(3):103-6. doi: 10.1016/j.prnil.2015.06.001. Epub 2015 Jul 17.

6.

When prostate cancer remains undetectable: The dilemma.

Mustafa MO, Pisters L.

Turk J Urol. 2015 Mar;41(1):32-8. doi: 10.5152/tud.2015.91249. Review.

7.

Comparison between ciprofloxacin and trimethoprim-sulfamethoxazole in antibiotic prophylaxis for transrectal prostate biopsy.

Atılgan D, Gençten Y, Kölükçü E, Kılıç Ş, Uluocak N, Parlaktaş BS, Erdemir F.

Turk J Urol. 2015 Mar;41(1):27-31. doi: 10.5152/tud.2015.22120.

8.

Complications of transrectal ultrasound-guided 12-core prostate biopsy: a single center experience with 2049 patients.

Efesoy O, Bozlu M, Çayan S, Akbay E.

Turk J Urol. 2013 Mar;39(1):6-11. doi: 10.5152/tud.2013.002.

9.

Rapid Identification of Rectal Multidrug-resistant Escherichia coli Before Transrectal Prostate Biopsy.

Tchesnokova VL, Ottley LL, Sakamoto K, Fierer J, Sokurenko E, Liss MA.

Urology. 2015 Dec;86(6):1200-5. doi: 10.1016/j.urology.2015.07.008. Epub 2015 Aug 20.

10.

Dual Processing Model for Medical Decision-Making: An Extension to Diagnostic Testing.

Tsalatsanis A, Hozo I, Kumar A, Djulbegovic B.

PLoS One. 2015 Aug 5;10(8):e0134800. doi: 10.1371/journal.pone.0134800. eCollection 2015.

11.

Importance of Local Control in Early-Stage Prostate Cancer: Outcomes of Patients With Positive Post-Radiation Therapy Biopsy Results Treated in RTOG 9408.

Krauss DJ, Hu C, Bahary JP, Souhami L, Gore EM, Chafe SM, Leibenhaut MH, Narayan S, Torres-Roca J, Michalski J, Zeitzer KL, Donavanik V, Sandler H, McGowan DG, Jones CU, Shipley WU.

Int J Radiat Oncol Biol Phys. 2015 Jul 15;92(4):863-73. doi: 10.1016/j.ijrobp.2015.03.017. Epub 2015 Mar 25.

12.

Prostate Biopsy Using Transrectal Ultrasonography; The Optimal Number of Cores Regarding Cancer Detection Rate and Complications.

Ghafoori M, Velayati M, Aliyari Ghasabeh M, Shakiba M, Alavi M.

Iran J Radiol. 2015 Apr 22;12(2):e13257. doi: 10.5812/iranjradiol.13257. eCollection 2015 Apr.

13.

Effect on hemostasis of an absorbable hemostatic gelatin sponge after transrectal prostate needle biopsy.

Kobatake K, Mita K, Kato M.

Int Braz J Urol. 2015 Mar-Apr;41(2):337-43. doi: 10.1590/S1677-5538.IBJU.2015.02.22.

14.

Short-term prophylaxis with ciprofloxacin in extended 16-core prostate biopsy.

Chambó RC, Tsuji FH, Yamamoto HA, Jesus CM.

Int Braz J Urol. 2015 Jan-Feb;41(1):46-56. doi: 10.1590/S1677-5538.IBJU.2015.01.08.

15.

Association between pre-biopsy white blood cell count and prostate biopsy - related sepsis.

Bulut S, Aktas BK, Gokkaya CS, Akdemir AO, Erkmen AE, Karabakan M, Memis A.

Cent European J Urol. 2015;68(1):86-90. doi: 10.5173/ceju.2015.01.508. Epub 2015 Mar 13.

16.

Role of information in preparing men for transrectal ultrasound guided prostate biopsy: a qualitative study embedded in the ProtecT trial.

Wade J, Rosario DJ, Howson J, Avery KN, Salter CE, Goodwin ML, Blazeby JM, Lane JA, Metcalfe C, Neal DE, Hamdy FC, Donovan JL.

BMC Health Serv Res. 2015 Feb 28;15:80. doi: 10.1186/s12913-015-0729-z.

17.

Complications of initial prostate biopsy in a European randomized screening trial.

van den Heuvel S, Loeb S, Zhu X, Verhagen PC, Schröder FH, Bangma CH, Roobol MJ.

Am J Clin Exp Urol. 2013 Dec 25;1(1):66-71. eCollection 2013.

18.

Febrile urinary tract infection after prostate biopsy and quinolone resistance.

Choi JW, Kim TH, Chang IH, Kim KD, Moon YT, Myung SC, Kim JW, Kim MS, Kwon JK.

Korean J Urol. 2014 Oct;55(10):660-4. doi: 10.4111/kju.2014.55.10.660. Epub 2014 Oct 10.

19.

Transperineal in-bore 3-T MR imaging-guided prostate biopsy: a prospective clinical observational study.

Penzkofer T, Tuncali K, Fedorov A, Song SE, Tokuda J, Fennessy FM, Vangel MG, Kibel AS, Mulkern RV, Wells WM, Hata N, Tempany CM.

Radiology. 2015 Jan;274(1):170-80. doi: 10.1148/radiol.14140221. Epub 2014 Sep 15.

20.

Personalized prostate cancer screening among men with high risk genetic predisposition- study protocol for a prospective cohort study.

Margel D, Benjaminov O, Ozalvo R, Shavit Grievink L, Kedar I, Yerushalmi R, Ben-Aharon I, Neiman V, Yossepowitch O, Kedar D, Levy Z, Shohat M, Brenner B, Baniel J, Rosenbaum E.

BMC Cancer. 2014 Jul 21;14:528. doi: 10.1186/1471-2407-14-528.

Supplemental Content

Support Center